A CLINICO-COMPARATIVE STUDY OF VARUN TAILA UTTARBASTI WITH AND WITHOUT SNEHAPANA IN THE MANAGEMENT OF MUTRAKRUCCHRA W.S.R. TO URETHRAL STRICTURE -An open-label randomized comparative clinical trial.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Result will be assessed on the basis of relief in painful micturition and improvement in urine flow in Mutrakrucchra
研究概览
简要总结
A CLINICO-COMPARATIVE STUDY OF VARUN TAILA UTTARBASTI WITH AND WITHOUT SNEHAPANA IN THE MANAGEMENT OF MUTRAKRUCCHRA W.S.R. TO URETHRAL STRICTURE -An open-label randomized comparative clinical trial
INTRODUCTION:
· Urethra, a tubular passage, is the organ of body which carries urine and seminal fluid in males and only urine in females.
· Urethral stricture is a narrowing of the urethra due to scar tissue, which leads to obstructive voiding dysfunction with potentially serious consequences for the entire urinary tract.
· The consequences of this obstruction can extremely impair the patient’s quality of life by causing micturition disturbances and resulting in loss of renal functions.
· Urethral strictures are more common in men because their urethra is longer than those in women. Thus, men’s urethra is more susceptible to disease or injury.
· In classical ayurvedic texts, the disease, in which patient feels difficulty in micturition is consider as Mutrakrucchra.
WHY THIS TOPIC SELECTED?
*·*In modern surgery effective therapy has been establish for the condition but more recurrences and complications. The discussion on surgical techniques and diagnostic methods of one of the oldest pathologies known to the urologist is still continuous. Thus, the urethral stricture remains a challenging pathology today. Hence there is need to find other treatment option for urethral stricture.
· In Ayurveda Mutrakrucchra caused by vitiated Vata dosa especially with its Ruksha Guna; hence Treatment of Vata dosa with Snigdha Guna dominant Dravya can reduce it.
· Taila considered best among Vata pacifying Dravya and it is one of the Uttama Sneha.
There is a reference that in Mutrakrucchra treatment should be planned according to Vatasthan and for Vatasthan - Basti is a choice of treatment hence Uttarbasti is selected for Mutrakrucchra.
Acharya Charak also mentioned Uttarbasti and Snehapana in the treatment plan of Vataja Mutrakrucchra.
· In Uttarbasti, Drug reduce the fibrosis in stricture part of urethra. In Snehapana, Drug reduce the Sanga from Mutravaha Srotasa, particularly at the urethra. As the Mutravaha Srotasa become free from vitiated Vata, considering all the views Varun Taila for Uttarbasti and Shwadamstradi Ghrita for Snehapana has been selected for the treatment in the patients of Mutrakrucchra.
NEED OF PRESENT STUDY:
· Urethral stricture is common urological problem of people due to lack of any kind of successful western medication there is intense and persistent scope to find out a simple medicine for relieving in the symptoms without any adverse effect on the urethra or urogenital tract.
· According to above keeping in the view Varun Taila for Uttarbasti and Shwadamstradi Ghrita for Snehapana has been selected for the treatment in the patients of Mutrakrucchra (Urethral Stricture)
RESEARCH QUESTION: · Whether there is any significant difference between Varun Taila Uttarbasti with Snehapana and without Snehapana in the management of Mutrakrucchra w.s.r. Urethral Stricture?
AIM:
• To assess the effect of Varun Taila Uttarbasti with Snehapana and without Snehapana in the management of Mutrakrucchra w.s.r. Urethral Stricture
OBJECTIVES:
• To evaluate the efficacy of Varun Taila Uttarbasti with Snehapana in the management of Mutrakrucchra w.s.r. Urethral Stricture
• To evaluate the efficacy of Varun Taila Uttarbasti without Snehapana in the management of Mutrakrucchra w.s.r. Urethral Stricture
DIAGNOSTIC CRITERIA:
• Sign and Symptoms of Mutrakrucchra (Urethral Stricture)
• Uroflowmetry
• RGU (Retrograde Urethrogram)
• USG-KUB if needed
STUDY DESIGN:
• Study Type : Open label randomized comparative clinical trial
• No. of Groups : 2 (10 patients in each group)
• Sample Size : 20 patients
• Location of study : Study will be conducted at Government Akhandanand Ayurved Hospital and Maniben Ayurved Hospital
DETAILS OF INTERVENTIONS:
â— Group A: Shwadamstradi Ghrita Snehapana followed by Varun Taila Uttarbasti in the management of Mutrakrucchra w.s.r. Urethral Stricture
â— Group B: Varun Taila Uttarbasti without Snehapana in the management of Mutrakrucchra w.s.r. Urethral Stricture
OBJECTIVE CRITERIA of Assessment (Before & After treatment):
• Uroflowmetry
• RGU ( Retrograde Urethrogram)
WITHDRAWL CRITERIA:
After the scheduled course, medicines will be withdrawn with proper consultation and future follow-up will be maintained
During the trial period, if any moderate to severe complications found, medication will be stopped
REPORTING ADR:
Adverse Drug Reaction (ADR), if observed will be registered and reported to Peripheral Pharmacovigilance Centre (PPvC), GAAC, Ahmedabad
DECLARATION:
The study will be completed in the stipulated time limit.
The work will be carried out after getting clearance from the institutional ethics committee.
The data related to the identification of the patient will be kept confidential.
The clinical data obtained will be summarized at the end of the study
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patient with age between 18 to 60 years Controlled case of Diabetes and Hypertension Patient having sign and symptoms of Mutrakrucchra (Urethral Stricture) fulfilling diagnostic criteria will be included.
排除标准
- •Patient below the age of 18 years or above the age of 60 years Patient have impacted calculus in the urethra and urinary bladder neck Benign Prostatic Hyperplasia Nephrotic syndrome and Neoplasm of lower urinary tract UTIs Patient with systemic disease like Asthma Epilepsy Autoimmune disorders Multiple Sclerosis Heart Disease Uncontrolled case of Diabetes and Hypertension Patient with HIV HBsAg STDs Patient with malignancy will be excluded.
结局指标
主要结局
Result will be assessed on the basis of relief in painful micturition and improvement in urine flow in Mutrakrucchra
时间窗: 21 days
次要结局
- Which procedure is more helpful in relieving the symptoms of Mutrakrucchra(2 Months)
研究者
Rajaneekant Rameshbhai Panchal
Government Akhandanand Ayurved College and Hospital
